from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1850/ureC

LFCtreatmentdescriptionclass of inhibitor

-0.082

Amikacinug/mL Amikacintranslation

-1.358

Cap5-10ug/mL Capreomycintranslation

-0.343

Rox10-50 ug/mL Roxithromycintranslation

-0.590

SM2-5 ug/mL Streptomycintranslation

-2.558

Tet5-10 ug/mL Tetracyclinetranslation

0.045

Rif0.2-5ug/mL Rifampicintranscription

-0.430

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.382

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.831

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.232

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.342

Clofazimine10-13 ug/mL Clofaziminerespiration

0.418

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.511

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.660

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.966

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.350

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.767

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.251

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.445

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.134

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.025

KCN5-20 ug/mL Potassium cyaniderespiration

-0.914

NaN30.2-2 mM Sodium aziderespiration

0.170

Nigericin50 uM Nigericinrespiration

-0.827

TRC10-150 ug/mL Triclosanrespiration

-0.924

TRZ10-25 ug/mL Thioridazinerespiration

2.185

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.013

menadione6-10 ug/mL Menadionerespiration

0.221

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.415

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.010

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.308

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.488

NRP_1Non-replicating persistence stage 1dosRassociated

0.343

Amp0.2mg/mL AmpicillincellWall

0.253

Cephalexin20-100 ug/mL CephalexincellWall

0.131

Cerulenin0.32-5 ug/mL CerulenincellWall

0.056

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.035

EMB10-20 ug/mL EthambutolcellWall

0.458

Eta12-40 ug/mL EthionamidecellWall

-0.222

INH0.2-0.4 ug/mL IsoniazidcellWall

0.358

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.400

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.061

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.184

BZA0.12 mg/mL BenzamidearomaticAmides

0.412

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.117

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.690

H2O24 mM hydrogen peroxideDNAdamaging

-0.164

Levo10 ug/mL LevofloxacinDNAdamaging

0.824

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.817

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.256

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.351

UVUV-irradiationDNAdamaging

-1.137

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.116

Antimycin12.5-50 ug/mL Antimycin A?

0.073

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.147

PA_110-50 ug/mL Antitubercular compound PA-1?

0.187

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.701

PA8240.2-2 ug/mL PA-824?

-1.775

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.018

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.220

Verapamil50 uM Verapamil?

0.129

mercaptoethanol2 mM 2-Mercaptoethanol?

0.376

methoxatin10-20 ug/mL Methoxatin?